Our deficient plasmas products are prepared from screened normal citrated human plasmas that have been tested and found negative for HIV and Hepatitis by FDA-approved methods. Our manufacturing process allows us to deplete plasma of specific target proteins by selective affinity immuno-adsorption, leaving other coagulation proteins intact. Affinity also has the capability to manufacture deficient plasma products to your specifications and even double or triple depleted.